Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993
- PMID: 9254902
- DOI: 10.1002/(sici)1097-0045(19970801)32:3<221::aid-pros9>3.0.co;2-n
Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993
Abstract
Background: Advances in medical and public health practice have led to many changes in patterns of prostate cancer care. Data from several studies of prostate cancer by the Commission on Cancer of the American College of Surgeons provide information on the directions, magnitudes, and consequences of these changes.
Methods: The Commission on Cancer conducts patient care evaluation (PCE) studies based on the voluntary participation of hospital cancer programs and their tumor registries. PCE studies have been conducted repeatedly for prostate cancer covering patients diagnosed as early as 1974 and as recently as 1990. In addition, the National Cancer Data Base of the Commission on Cancer collects data for all forms of cancer from throughout the country. The Commission on Cancer, the American Cancer Society, and the American Urologic Association also has conducted a focused survey of radical prostatectomy outcomes. In aggregate, these multiple studies have accrued 179,366 reports on treatment of prostate cancer patients.
Results: Predominant among practice changes are new techniques of prostate cancer detection and initial evaluation which have led to shifts in disease stage at the time of initial therapy. The proportion of prostate cancer that is localized at the time of detection has increased. Use of radiation therapy and radical prostatectomy has increased as the selection of hormone treatment and no cancer-directed treatment have decreased. Five-year prostate cancer survival has improved for every stage of disease.
Conclusions: The multiple studies by the Commission on Cancer provide data that are not available from other sources. Continued monitoring of prostate cancer patterns of care may be useful in measuring progress in control of this common disease.
Similar articles
-
The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.Cancer. 1998 Oct 15;83(8):1679-84. doi: 10.1002/(sici)1097-0142(19981015)83:8<1679::aid-cncr24>3.0.co;2-y. Cancer. 1998. PMID: 9781963
-
The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society.Cancer. 1995 Sep 15;76(6):1104-12. doi: 10.1002/1097-0142(19950915)76:6<1104::aid-cncr2820760627>3.0.co;2-d. Cancer. 1995. PMID: 8625214
-
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.J Am Coll Surg. 1995 May;180(5):545-54. J Am Coll Surg. 1995. PMID: 7538405
-
Prostate cancer 2004: insights from national disease registries.Oncology (Williston Park). 2004 Sep;18(10):1239-47; discussion 1248-50, 1256-8. Oncology (Williston Park). 2004. PMID: 15526829 Review.
-
Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality.J Clin Endocrinol Metab. 1995 Jul;80(7):2002-13. doi: 10.1210/jcem.80.7.7541800. J Clin Endocrinol Metab. 1995. PMID: 7541800 Review.
Cited by
-
Androgen deprivation therapy: a cornerstone in the treatment of advanced prostate cancer.Rev Urol. 2004;6 Suppl 8(Suppl 8):S3-9. Rev Urol. 2004. PMID: 16985918 Free PMC article.
-
Bicalutamide adjuvant to radical prostatectomy.Rev Urol. 2004;6 Suppl 2(Suppl 2):S20-8. Rev Urol. 2004. PMID: 16985857 Free PMC article.
-
Growth hormone and prostate cancer: guilty by association?J Endocrinol Invest. 1999;22(5 Suppl):64-73. J Endocrinol Invest. 1999. PMID: 10442574 Free PMC article. Review.
-
Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA.BMC Cancer. 2005 Mar 8;5:27. doi: 10.1186/1471-2407-5-27. BMC Cancer. 2005. PMID: 15755329 Free PMC article.
-
Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis.Cancer Biol Ther. 2017 Nov 2;18(11):872-882. doi: 10.1080/15384047.2016.1219817. Epub 2016 Sep 13. Cancer Biol Ther. 2017. PMID: 27624889 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical